Ä¢¹½ÊÓƵ

MITSUBISHI CHEMICAL GROUP
MITSUBISHI CHEMICAL GROUP

Approval of Mounjaro, the world¡¯s first sustained release GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes in Japan

September 26, 2022

Mitsubishi Tanabe Pharma Corporation, a member of the Ä¢¹½ÊÓƵ, has announced the following press release.

¡öMitsubishi Tanabe Pharma¡¡Press Release
Approval of Mounjaro, the world’s first sustained release GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes in Japan

?Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top